The Government of Maharashtra has waived development charges for all projects undertaken by the Tata Memorial Centre (TMC) across the state. The Urban Development Department issued a notification confirming the decision, acknowledging that despite its global reputation, the institute lacks sufficient financial resources to bear high development premiums and charges.
TMC Granted Government-Equivalent Status
Under the new directive, authorities will treat TMC on par with government institutions. Consequently, it will receive full exemption from development charges and development cess imposed under the Development Control and Promotion Regulations. This exemption applies not only to hospital buildings but also to ancillary infrastructure such as staff quarters, dharmashalas, and administrative facilities.
Major Projects to Benefit
Importantly, the waiver will support several key expansion initiatives. These include TMC’s large-scale redevelopment project in Parel, a proposed 100-bed Ayurveda-based cancer hospital and research centre in Khopoli, and a dedicated women and children’s wing at its Kharghar facility. As a result, the institution can accelerate infrastructure development aimed at expanding access to cancer care.
₹252 Crore Premium Waived for Parel Expansion
Earlier, the Brihanmumbai Municipal Corporation (BMC) had demanded ₹252 crore as a premium for TMC’s expansion on the Haffkine Bio Pharma Corporation Limited plot in Parel. However, following the state government’s decision, the hospital will no longer need to pay this amount, significantly easing its financial burden.
Policy Backed by Legal Provisions
As reported by Hindustan Times, the exemption aligns with provisions under the Maharashtra Regional and Town Planning Act, 1966. While Section 124(a) mandates development charges on land and building projects, Section 124(f) allows exemptions for properties owned by government bodies. Acting on this provision, and following approvals from the finance department (December 24, 2025) and the state cabinet (March 5, 2026), the government granted TMC similar relief.
Supporting a High-Impact Public Health Institution
TMC, a non-profit institution under the Department of Atomic Energy, treats approximately 10,000 cancer patients annually. Notably, around 60% of patients receive highly subsidised or nearly free treatment, primarily benefiting economically weaker sections. Given its grant-in-aid status and financial constraints, the waiver acknowledges the institute’s critical role in public health.
Leadership Welcomes the Decision
Dr. Shailesh V. Shrikhande, Chief Executive of Tata Cancer Care Foundation and Officer on Special Duty for TMC’s ₹880 crore expansion project, welcomed the move. He emphasised that the decision reflects strong collaboration between central, state, and local authorities to support patients during critical times. He also highlighted plans to expand capacity and strengthen cancer care training programs.
Similarly, TMC Director Dr. Sudeep Gupta expressed gratitude to the state government for granting the exemption, noting that it will significantly enhance the institution’s ability to scale services.
Boost to Affordable Cancer Care
Overall, the waiver marks a major policy step toward strengthening affordable cancer care infrastructure in Maharashtra. By reducing financial barriers, the government has enabled TMC to focus on expanding services, improving accessibility, and advancing patient-centric care across the state.